Tetsuro Ikegami. (2017). Rift Valley fever vaccines: An overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate. Taylor & Francis Group.
Chicago Style (17th ed.) CitationTetsuro Ikegami. Rift Valley Fever Vaccines: An Overview of the Safety and Efficacy of the Live-attenuated MP-12 Vaccine Candidate. Taylor & Francis Group, 2017.
MLA (9th ed.) CitationTetsuro Ikegami. Rift Valley Fever Vaccines: An Overview of the Safety and Efficacy of the Live-attenuated MP-12 Vaccine Candidate. Taylor & Francis Group, 2017.
Warning: These citations may not always be 100% accurate.